Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Neural Control of Respiration01:18

Neural Control of Respiration

The neural regulation of respiration is a meticulously coordinated process primarily controlled by the respiratory centers located within the brainstem. These centers, composed of specialized neurons, transmit nerve impulses that control the contraction and relaxation of our respiratory muscles.
Respiratory Centers in the Brainstem
Two primary areas comprise the respiratory center: the medullary respiratory center in the medulla oblongata and the pontine respiratory group in the pons. The...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantification of Ventilatory Control in Sleep Apnea: From Physiological Insight to Computable Loop Gain.

Sleep·2026
Same author

PMB-NN: Physiology-centered hybrid AI for personalized hemodynamic monitoring from photoplethysmography.

Computer methods and programs in biomedicine·2026
Same author

Association Between Preadmission β-Blocker Use and Venoarterial Extracorporeal Membrane Oxygenation Weaning Failure in Patients With Cardiogenic Shock.

Journal of the American Heart Association·2026
Same author

Spoilt for choice? Temporary mechanical circulatory support in cardiogenic shock: The importance of the patient.

Perfusion·2026
Same author

Exploring weaning-related shock: Cardiac injury and overload, platelet-endothelial cell activation, and inflammatory response markers following ECMO decannulation.

Perfusion·2026
Same author

Standardization of In-Vitro Evaluation of Extracorporeal Life Support (ECLS) Devices for Research and Development.

Interdisciplinary cardiovascular and thoracic surgery·2026

相关实验视频

Updated: May 12, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K

基于深度强化学习的左心室辅助器件的生理控制.

Diego Fernández-Zapico, Thijs Peirelinck1, Geert Deconinck1

  • 1Department of Electrical Engineering (ESAT), KU Leuven, Leuven, Belgium.

Artificial organs
|September 18, 2024
PubMed
概括

这项研究引入了用于左心室辅助器件 (LVAD) 的新型深度强化学习控制器,以改善心力衰竭患者的结果. 与传统方法相比,新的控制器增强了主动脉流量和终端透析体积稳定性.

关键词:
一个心肺呼吸模拟器.深度强化学习的学习.心脏衰竭是因为心脏衰竭.左心室辅助装置的使用生理控制生理控制

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.8K

相关实验视频

Last Updated: May 12, 2026

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
08:49

Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart

Published on: May 11, 2018

9.4K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.5K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

1.8K

科学领域:

  • 生物医学工程 生物医学工程
  • 人工智能在医学中的应用
  • 心血管生理学心血管生理学

背景情况:

  • 心力衰竭 (HF) 对健康造成重大负担,需要先进的左心室辅助装置 (LVAD) 技术.
  • 目前的LVAD控制策略存在局限性,强化学习 (RL) 应用尚未得到充分探索.
  • 这项研究的重点是改善LVAD控制,以改善严重HF患者的治疗结果.

研究的目的:

  • 为LVAD引入一种新的基于预加载的深度强化学习 (DRL) 控制器.
  • 通过优化患者的血液动力学来提高LVAD性能.
  • 使用先进的人工智能解决当前LVAD控制策略的局限性.

主要方法:

  • 开发了一个使用近接策略优化算法的DRL控制器.
  • 利用具有各种生理参数的高保真心呼吸模拟器来模拟患者的变化.
  • 训练了DRL控制器,以防止心室吸收,并确保使用关键的LV压力信号来确保大动脉的打开.

主要成果:

  • 与常速LVAD (9mL SD) 相比,DLR控制器表现出优异的终端扩张体积 (EDV) 稳定性 (5mL SD).
  • 通过DRL控制器实现更高的大动脉流量 (平均1.1L/分钟),而不是常速LVAD (0.9L/分钟).
  • 控制器有效地管理了模拟严重HF群体中的血液动力学参数.

结论:

  • 一个基于DRL的控制器在一个复杂的心肺呼吸模拟器中成功实施和验证.
  • DRL控制器显著改善了大动脉流量和EDV稳定性,而不是标准的常速LVAD.
  • 这种方法对推进LVAD技术和管理心力衰竭有前途.